Sfmg LLC Buys 56 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

by · The Cerbat Gem

Sfmg LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 3.8% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,537 shares of the healthcare conglomerate’s stock after purchasing an additional 56 shares during the period. Sfmg LLC’s holdings in UnitedHealth Group were worth $898,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the company. World Investment Advisors LLC increased its stake in shares of UnitedHealth Group by 239.4% in the third quarter. World Investment Advisors LLC now owns 41,575 shares of the healthcare conglomerate’s stock valued at $24,308,000 after buying an additional 29,324 shares in the last quarter. Sanctuary Advisors LLC lifted its position in shares of UnitedHealth Group by 17.0% during the third quarter. Sanctuary Advisors LLC now owns 145,278 shares of the healthcare conglomerate’s stock worth $85,841,000 after purchasing an additional 21,084 shares in the last quarter. Pine Valley Investments Ltd Liability Co increased its holdings in shares of UnitedHealth Group by 5.2% in the third quarter. Pine Valley Investments Ltd Liability Co now owns 18,963 shares of the healthcare conglomerate’s stock valued at $11,087,000 after purchasing an additional 930 shares in the last quarter. Anchor Investment Management LLC lifted its holdings in UnitedHealth Group by 5.1% during the 3rd quarter. Anchor Investment Management LLC now owns 23,310 shares of the healthcare conglomerate’s stock worth $13,629,000 after buying an additional 1,128 shares in the last quarter. Finally, Tudor Financial Inc. bought a new stake in shares of UnitedHealth Group during the third quarter worth $900,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research reports. Cantor Fitzgerald upped their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Oppenheimer raised their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Truist Financial reissued a “buy” rating and issued a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Bank of America dropped their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $626.84.

Check Out Our Latest Stock Analysis on UNH

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $533.53 on Thursday. The stock has a market capitalization of $491.00 billion, a price-to-earnings ratio of 34.75, a PEG ratio of 1.65 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The business has a 50-day moving average of $584.83 and a 200-day moving average of $559.60. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same period last year, the firm posted $6.56 earnings per share. The business’s revenue was up 9.2% on a year-over-year basis. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.57%. UnitedHealth Group’s payout ratio is presently 54.72%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also